CCRM
Janet Rothberg is an accomplished expert in stem cell research and molecular biology, currently serving as the Director at CCRM since February 2016. Janet has held various developmental roles at CCRM, including Senior Development Manager and Development Scientist. Previously, Janet was a Graduate Student at the Ottawa Hospital Research Institute from September 2009 to 2016, focusing on the role of Polycomb proteins in hematopoietic development and leukemogenesis. Janet has contributed significantly to science communication and education, coordinating workshops for the Stem Cell Network and engaging with the Let's Talk Science initiative. Janet's academic credentials include a PhD in Stem Cell Research from the University of Ottawa and an MSc in Physiology and Molecular Biology from Western University.
This person is not in any teams
CCRM
1 followers
Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today. Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and engineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011. CCRM supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy.